Overview
Highlights from the 12th Annual Linda Morgante MS Nurse Leadership Program
Click the "View Activity" button to view this activity.
View ActivityActivity already occured. CME/CE is no longer available for this activity
This enduring activity features three presentations from the 12th Annual Linda Morgante MS Nurse Leadership Program held virtually on June 26, 2021. These presentations provide multiple sclerosis (MS) nurses access to the latest evidence and strategies related to treatment selection, treat-to-target approaches, and symptom management as part of comprehensive patient care to improve outcomes.
This activity is intended for nurses and advanced practice clinicians who manage patients with multiple sclerosis (MS).
The goal of this highlight activity from the 12th Annual Linda Morgante MS Nurse Leadership Program is to provide nurses in MS with the opportunity to develop and refine their skill set and provide access to the latest evidence and strategies related to treatment selection, treat-to-target approaches, and symptom management as part of comprehensive patient care to improve outcomes.
Upon completion of this activity, participants will be able to:
- Apply evidence-based assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS
- Improve patient outcomes and adherence to therapy by identifying, assessing, and managing emerging MS-related symptoms and DMT-related adverse events
- Employ treat-to-target strategies and precision medicine to improve patient long-term outcomes
Supported by educational grants from Bristol-Myers Squibb, EMD Serono, Inc., Greenwich Biosciences, Inc., Novartis Pharmaceuticals Corporation and Sanofi Genzyme.
- Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
- Compatible with Windows PC and MAC (256 MB of RAM or higher)
- Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
- Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
- Adobe Reader to print certificate. Click here to download Adobe Reader for free.
- Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run
- Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Provided by the Academy for Continued Healthcare Learning and Annenberg Center for Health Sciences at Eisenhower.
Chairs
Colleen Harris, MN, NP, MSCN, MSCS
Nurse Practitioner
University of Calgary MS Clinic
Calgary, Alberta, Canada
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Maywood, Illinois
Faculty
Cheryl Blaschuk, NP, MSN
Nurse Practitioner
Medical College of Wisconsin
Comprehensive Multiple Sclerosis Clinic
Froedtert & Medical College of Wisconsin
Wauwatosa, Wisconsin
Constance Easterling, MSN, ARNP, MSCN
Advanced Practice Registered Nurse
Research consultant
MS Care Center
Neurological Services of Orlando
Orlando, Florida
Marie Namey, APRN, MSCN
MS Nurse Consultant
Recently retired from Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research
Cleveland, Ohio
The Annenberg Center for Health Sciences at Eisenhower (ACHS) and ACHL require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and mitigated according to the ACHS' policy. ACHS is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ACCME-defined ineligible company.
The following financial relationships have been provided:
Constance Easterling, MSN, ARNP, MSCN
Discussion of off-label agents for MS fatigue, neuropathic pain, MS spasticity, cerebellar dysfunction, and sexual dysfunction as well as discussion of investigational nabiximols
Colleen Harris, MN, NP (Chair)
Consulting Agreements: BMS; EMD Serono; Sanofi
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Amy Perrin Ross, APN, MSN, CNRN, MSCN (Chair)
Consulting Agreements: Alexion; Biogen; EMD Serono; Genentech; Genzyme; Horizon; Janssen; Mallinckrodt; Novartis; Roche
Board Member: CMSC; IOMSN
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Marie Namey, APRN, MSCN
Consulting Agreements: Biogen; EMD Serono; Genentech; Novartis; Sanofi; Viela Bio
Speakers' Bureau: Biogen; Genentech; Novartis; Sanofi
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Discussion of investigational amantadine, arbaclofen, nabiximols, ublituximab, evobrutinib, fenebrutinib, masitinib, and tolebrutinib
The following faculty have no relevant financial relationships to disclose, and will not be discussing off-label, investigational, or experimental drug use:
Cheryl Blaschuk, NP, MSN
ACHL and ACHS staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the ANCC Accreditation Program. Recommendations involving clinical medicine in a continuing education (CE) activity which state content must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHS and ACHL require the speaker to disclose that a product is not labeled for the use under discussion.
This activity is segmented into 3 modules, will take approximately, 120 minutes to complete. To receive credit, participants are required to complete the pretest, participate in the enduring activity, and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Katie Hacias at khacias@achlcme.org
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 2.0 contact hours, which includes 1.25 pharmacology hours, may be earned for successful completion of this activity.
